Seller record · getmedro.com

Medro

Fails 1 of 8 criteria. S5, analytical documentation: No certificate, lot report or test document is published. The product pages stop at a statement of oversight into how medication is sourced, tested and delivered.

At a glance

Medrogetmedro.com

7/8criteria passed
Price
Semaglutide $99 a month (sale; regular $199)
Sells
compounded semaglutide, compounded tirzepatide, and 7 more
FDA letters
None on file
Visit MedroSee all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide, including microdose plans, and sermorelin, NAD+, glutathione and a GHK-Cu hair foam. It names The Pharmacy Hub in Miami as its pharmacy, and its product prices are sale prices set beside struck regular prices.

Operating entity Medro Health Technologies, Inc.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSgetmedro.com, getmedro.com/medical-provider
S2Prescription gatingPASSstart.getmedro.com/start-online-visit/weightloss
S3Pharmacy identificationPASSgetmedro.com/faq
S4Compounding disclosurePASSgetmedro.com, getmedro.com/microdose-glp1
S5Analytical documentationFAILgetmedro.com/glp1
S6Business addressPASSgetmedro.com/contact, getmedro.com/privacy
S7Price disclosurePASSgetmedro.com/glp1, getmedro.com/sermorelin, getmedro.com/nad
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSTreatment decisions are made only after review by a licensed clinician, and the answers name the clinical provider as Arora Health and Aesthetics, LLC in Seattle.Source: getmedro.com, getmedro.com/medical-provider.
S2PASSThe start button opens a weight loss intake whose first question asks the buyer's reasons for seeking treatment, and no cart exists on the storefront.Source: start.getmedro.com/start-online-visit/weightloss.
S3PASSThe answers name The Pharmacy Hub at 15600 NW 15th Ave, Suite C, Miami, FL 33169 as the partner pharmacy, with its telephone number.Source: getmedro.com/faq.
S4PASSCompounded medications are not approved by the FDA, printed beneath the home page catalog and in the microdose answers, though the main GLP-1 page says only compounded in the USA and a home page banner says branded medication only.Source: getmedro.com, getmedro.com/microdose-glp1.
S5FAILNo certificate, lot report or test document is published. The product pages stop at a statement of oversight into how medication is sourced, tested and delivered.Source: getmedro.com/glp1.
S6PASSMedro Health Technologies, Inc. at 2261 Market Street STE 18557, San Francisco, CA 94114, printed on the contact page, in the privacy policy and in the terms.Source: getmedro.com/contact, getmedro.com/privacy.
S7PASSSemaglutide from $99 a month as a sale price against a struck regular $199 a month, with a $99 discount applied to the first plan; tirzepatide from $199 against $299, sermorelin from $109 against $149 and NAD+ from $99 against $179.Source: getmedro.com/glp1, getmedro.com/sermorelin, getmedro.com/nad.
S8PASSNo FDA warning letter names Medro or the operating entity Medro Health Technologies, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, microdose semaglutide and tirzepatide, sermorelin, NAD+ injection and nasal spray, glutathione injection and nasal spray, GHK-Cu hair foam, MIC+B12, vitamin B12.

Unpaid link. Medro does not pay the site, and nothing is earned when it is used. Funding.

Visit Medro

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.